Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators

por Segura-Collar, Berta, Hiller-Vallina, Sara, de Dios, Olaya, Caamaño-Moreno, Marta, Mondejar-Ruescas, Lucia, Sepulveda-Sanchez, Juan M., Gargini, Ricardo
Publicado 2023

Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators

por Segura-Collar, Berta, Hiller-Vallina, Sara, de Dios, Olaya, Caamaño-Moreno, Marta, Mondejar-Ruescas, Lucia, Sepulveda-Sanchez, Juan M., Gargini, Ricardo
Publicado 2023

On optimal temozolomide scheduling for slowly growing glioblastomas

por Segura-Collar, Berta, Jiménez-Sánchez, Juan, Gargini, Ricardo, Dragoj, Miodrag, Sepúlveda-Sánchez, Juan M, Pešić, Milica, Ramírez, María A, Ayala-Hernández, Luis E, Sánchez-Gómez, Pilar, Pérez-García, Víctor M
Publicado 2022

Ocoxin Modulates Cancer Stem Cells and M2 Macrophage Polarization in Glioblastoma

por Hernández-SanMiguel, Esther, Gargini, Ricardo, Cejalvo, Teresa, Segura-Collar, Berta, Núñez-Hervada, Paula, Hortigüela, Rafael, Sepúlveda-Sánchez, Juan M., Hernández-Laín, Aurelio, Pérez-Núñez, Angel, Sanz, Eduardo, Sánchez-Gómez, Pilar
Publicado 2019

Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study

por Kovacs, Richard J., Maldonado, Giuliana, Azaro, Analia, Fernández, Maria S., Romero, Federico L., Sepulveda-Sánchez, Juan M., Corretti, Mary, Carducci, Michael, Dolan, Melda, Gueorguieva, Ivelina, Cleverly, Ann L., Pillay, N. Sokalingum, Baselga, Jose, Lahn, Michael M.
Publicado 2014

Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype

por Cejalvo, Teresa, Gargini, Ricardo, Segura-Collar, Berta, Mata-Martínez, Pablo, Herranz, Beatriz, Cantero, Diana, Ruano, Yolanda, García-Pérez, Daniel, Pérez-Núñez, Ángel, Ramos, Ana, Hernández-Laín, Aurelio, Martín-Soberón, María Cruz, Sánchez-Gómez, Pilar, Sepúlveda-Sánchez, Juan M.
Publicado 2020

Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced canc...

por Rodón, Jordi, Carducci, Michael, Sepulveda-Sánchez, Juan M., Azaro, Analía, Calvo, Emiliano, Seoane, Joan, Braña, Irene, Sicart, Elisabet, Gueorguieva, Ivelina, Cleverly, Ann, Pillay, N. Sokalingum, Desaiah, Durisala, Estrem, Shawn T., Paz-Ares, Luis, Holdhoff, Matthias, Blakeley, Jaishri, Lahn, Michael M., Baselga, Jose
Publicado 2014

Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine

por Capper, David, von Deimling, Andreas, Brandes, Alba A., Carpentier, Antoine F., Kesari, Santosh, Sepulveda-Sanchez, Juan M., Wheeler, Helen R., Chinot, Olivier, Cher, Lawrence, Steinbach, Joachim P., Specenier, Pol, Rodon, Jordi, Cleverly, Ann, Smith, Claire, Gueorguieva, Ivelina, Miles, Colin, Guba, Susan C., Desaiah, Durisala, Estrem, Shawn T., Lahn, Michael M., Wick, Wolfgang
Publicado 2017